Orange Book product · Generic (ANDA)
ADENOSINE
ADENOSINE
At a glance
Sep 15, 2014
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 15, 2014
11 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ADENOSINE
Strength
60MG/20ML (3MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
AP
Application
ANDA 202313
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ADENOSINE
- 1995ADENOSCANBrand (NDA)
NDA 020059 · ASTELLAS
- 1989ADENOCARDBrand (NDA)
NDA 019937 · ASTELLAS
- 2018ADENOSINEGeneric (ANDA)
ANDA 205568 · FRESENIUS KABI USA
- 2018ADENOSINEGeneric (ANDA)
ANDA 206778 · GLAND
- 2017ADENOSINEGeneric (ANDA)
ANDA 077897 · FRESENIUS KABI USA
- 2017ADENOSINEGeneric (ANDA)
ANDA 205331 · EUGIA PHARMA
- 2014ADENOSINEGeneric (ANDA)
ANDA 090450 · RISING
- 2014ADENOSINEGeneric (ANDA)
ANDA 090212 · MYLAN ASI
- 2014ADENOSINEGeneric (ANDA)
ANDA 203883 · HOSPIRA
- 2014ADENOSINEGeneric (ANDA)
ANDA 078640 · PHARMOBEDIENT
- 2013ADENOSINEGeneric (ANDA)
ANDA 077425 · MEITHEAL
- 2009ADENOSINEGeneric (ANDA)
ANDA 090220 · WOCKHARDT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
